Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HAH9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 176 | 180 | PF00656 | 0.351 |
CLV_C14_Caspase3-7 | 201 | 205 | PF00656 | 0.542 |
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.509 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.519 |
CLV_NRD_NRD_1 | 189 | 191 | PF00675 | 0.306 |
CLV_NRD_NRD_1 | 193 | 195 | PF00675 | 0.458 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.316 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.360 |
CLV_PCSK_FUR_1 | 170 | 174 | PF00082 | 0.567 |
CLV_PCSK_FUR_1 | 187 | 191 | PF00082 | 0.316 |
CLV_PCSK_KEX2_1 | 171 | 173 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 189 | 191 | PF00082 | 0.297 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.578 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.311 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.360 |
CLV_PCSK_PC1ET2_1 | 171 | 173 | PF00082 | 0.552 |
CLV_PCSK_PC1ET2_1 | 2 | 4 | PF00082 | 0.597 |
CLV_PCSK_PC7_1 | 185 | 191 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.590 |
DEG_APCC_DBOX_1 | 177 | 185 | PF00400 | 0.573 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.637 |
DOC_PP1_RVXF_1 | 34 | 41 | PF00149 | 0.355 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.631 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.556 |
DOC_USP7_UBL2_3 | 2 | 6 | PF12436 | 0.631 |
LIG_14-3-3_CanoR_1 | 189 | 197 | PF00244 | 0.426 |
LIG_FHA_1 | 160 | 166 | PF00498 | 0.528 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.397 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.410 |
LIG_LIR_Gen_1 | 139 | 148 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 139 | 145 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 59 | 63 | PF02991 | 0.300 |
LIG_PDZ_Class_3 | 204 | 209 | PF00595 | 0.587 |
LIG_Pex14_1 | 56 | 60 | PF04695 | 0.300 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.434 |
LIG_SH2_GRB2like | 16 | 19 | PF00017 | 0.360 |
LIG_SH2_STAT3 | 63 | 66 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.303 |
LIG_TRAF2_1 | 64 | 67 | PF00917 | 0.434 |
LIG_TYR_ITSM | 138 | 145 | PF00017 | 0.332 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.693 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.577 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.634 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.428 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.577 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.410 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.723 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.579 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.403 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.638 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.530 |
MOD_N-GLC_1 | 118 | 123 | PF02516 | 0.655 |
MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.367 |
MOD_N-GLC_2 | 73 | 75 | PF02516 | 0.300 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.631 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.407 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.277 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.531 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.483 |
MOD_PKA_2 | 177 | 183 | PF00069 | 0.525 |
MOD_PKA_2 | 188 | 194 | PF00069 | 0.381 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.197 |
MOD_Plk_2-3 | 122 | 128 | PF00069 | 0.587 |
TRG_DiLeu_BaEn_4 | 152 | 158 | PF01217 | 0.498 |
TRG_ENDOCYTIC_2 | 142 | 145 | PF00928 | 0.425 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.300 |
TRG_ER_diArg_1 | 169 | 172 | PF00400 | 0.580 |
TRG_NLS_MonoCore_2 | 169 | 174 | PF00514 | 0.346 |
TRG_NLS_MonoExtC_3 | 169 | 174 | PF00514 | 0.346 |
TRG_NLS_MonoExtN_4 | 168 | 175 | PF00514 | 0.344 |
TRG_Pf-PMV_PEXEL_1 | 163 | 167 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAJ2 | Leptomonas seymouri | 63% | 100% |
A0A0S4KI64 | Bodo saltans | 44% | 92% |
A0A1X0PAK0 | Trypanosomatidae | 40% | 87% |
A0A3S7X7J4 | Leishmania donovani | 77% | 74% |
A0A422MR74 | Trypanosoma rangeli | 41% | 91% |
A4IAN9 | Leishmania infantum | 77% | 74% |
C9ZN14 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 73% |
E9B4N9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4Q3D7 | Leishmania major | 79% | 100% |
V5BJE2 | Trypanosoma cruzi | 39% | 71% |